For Healthcare CFOs — Marketing P&L Attribution | ICG Enterprise

Schema: Service + FAQPage + Person Word count: ~2,000

Author: Abhash Kumar · Co-Founder, ICG · IIT BHU + IIM Bangalore · July 2026

The CFO's marketing problem

The CFO's relationship with the marketing budget is adversarial by default. Marketing comes to the budget meeting with CPL data, campaign performance metrics, and impression charts. The CFO's question is: what did the ₹3.2 crore in marketing spend generate in procedure revenue last quarter?

The CMO cannot answer. Not definitively. Not with a number the CFO can put in a board pack.

This is not a marketing failure. It is a systems failure. The marketing system, the patient coordination system, and the finance system do not speak to each other. Revenue is recorded by department — not by how the patient arrived.

ICG's programme for healthcare CFOs closes this systems gap. The output: a marketing P&L that the CFO can verify, defend at board, and use to make evidence-based marketing budget decisions.

The three numbers every healthcare CFO needs from marketing

Number 1 — CPQL by specialty: Cost per qualified lead — cost per attended first consultation — broken out by specialty. This is the efficiency metric that tells the CFO whether the cardiology OPD acquisition cost is below or above the ICG benchmark (₹1,650) and whether that cost is trending toward or away from it.

For the CFO: CPQL by specialty allows you to assess marketing efficiency the same way you assess operational efficiency — against a benchmark, with a trend, and with a specific action recommendation when it deviates.

Number 2 — Marketing revenue attribution: What ₹ value of procedure revenue is attributable to marketing-sourced patient consultations this quarter. ICG's Beacon attribution chain: media spend → WhatsApp enquiry → consultation attended → procedure booked → HIS procedure code → revenue recognised. Most hospitals can attribute 47–62% of consultation revenue to marketing at engagement start. ICG's target: 80%+ within 8 months.

For the CFO: this is the number that belongs in the board pack alongside the marketing budget line. "We spent ₹3.2 crore on marketing. We attributed ₹X crore in procedure revenue to that investment." This transforms marketing from a cost centre line item into a revenue-generating investment.

Number 3 — MRR:CAC ratio: Monthly recurring revenue (procedure revenue from returning patients + subscription health programmes) relative to cost of acquisition. This is the LTV-to-CAC metric — the ratio that tells the CFO whether the marketing investment is generating sticky, compounding patient relationships or one-time consultations.

ICG reference: Delhi NCR hospital group engagement — MRR:CAC 3.2× at engagement start → 8.4× at month 18. The improvement came from three sources: CPQL reduction (lower acquisition cost), Hawk re-engagement (converting 22% of limbo leads at ₹0 additional cost), and organic consultation share growth (reducing media dependency).

The marketing P&L structure ICG produces

Monthly board-ready report format:

This report exists in Agency OS dashboard form (live data) and PDF format (for board circulation). The Co-Founder reviews and signs off before delivery to the CFO.

Case study: Tier-2 cardiac hospital CFO

At engagement start: marketing spend ₹18 lakh/month. No attribution. CFO's question: "Is this money well spent?"

Month 4 (first clean attribution report): 68% of consultation revenue now attributable. Real CPQL: ₹1,620 (cardiology OPD). GP referral programme added: 29% of cardiac OPD now from GP referral at ₹0 media cost.

Month 8: 79% attribution. CFO to hospital owner: "I can defend the marketing spend monthly now. ₹18 lakh generates [specific consultations] at [specific CPQL] with 79% revenue attribution."

(Anonymised. Full case: /case-studies/anonymised-tier-2-cardiac-hospital-revops)

FAQ

Q: What is the difference between CPQL and ROAS for a healthcare CFO? ROAS (Return on Ad Spend) measures media efficiency — how much revenue was generated for each rupee of media spend. CPQL measures patient acquisition efficiency — the cost of generating one attended consultation. ROAS is a useful media metric. CPQL is the business metric — it connects to procedure revenue, to procedure mix, to the financial model. ROAS tells you which campaigns are efficient. CPQL tells you which marketing investments are generating the patients the hospital needs.

Q: How does ICG's Beacon attribution connect to the HIS/PMS for procedure revenue tracking? Beacon's offline conversion import connects the CRM's consultation attendance events to Google and Meta — attributing the consultation to the original ad. For the procedure revenue chain: ICG integrates with the HIS/PMS at the patient ID level (DPDP-compliant, data is hashed and anonymised before any transmission). The procedure code recorded in the HIS for a Beacon-attributed patient can be matched to the consultation event, enabling procedure revenue attribution. This is a 4–6 week implementation beyond standard Beacon deployment — and requires IT team involvement from the hospital.

Q: What is the typical attribution rate improvement timeline? Month 1–2: 47–62% (baseline, from the diagnostic). Month 4: 65–72% (Beacon CAPI + CRM source capture deployed). Month 6–8: 76–85% (offline conversion import live, algorithm trained, GP referral programme capturing previously invisible referral traffic). Month 8+: 80–85% sustained — the remaining 15–20% represents unattributable walk-ins and peer referrals.

Downloadable: Marketing P&L Template (Excel/Google Sheets) → Download: /downloads/healthcare-marketing-board-report-template

Contact: /book?type=enterprise | +91 81302 26224 | contact@ichelonconsulting.com